Idiopathic pulmonary fibrosis: Pirfenidone
![Feature image](https://healthsci.mcmaster.ca/wp-content/uploads/2023/07/ipf-pirfenidonec98464ab75f14fd18bbe539db37cc9b4.jpg)
The effects, mechanism of action and clinical trials for pirfenidone as a treatment for IPF.
Pirfenidone is an approved pharmacological agent for the treatment of Idiopathic Pulmonary Fibrosis (IPF). This video attempts to explain the effects, mechanism of action and clinical trials for pirfenidone.
[Please complete our feedback form]
Demystifying Medicine, Education, Idiopathic pulmonary fibrosis (IPF)
Related News
News Listing
![](https://healthsci.mcmaster.ca/wp-content/uploads/2024/06/McCall-MacBain-International-Fellows-2024-1.png)
Daily News ➚
5 McMaster students named McCall MacBain International Fellows
Collaborations & Partnerships, Education, Funding
3 days ago
![](https://healthsci.mcmaster.ca/wp-content/uploads/2024/06/Hannah-Snyder-headshot-photo-1200x675-1.jpg)
Department of Pediatrics ➚
Behind the White Coat: A conversation with pediatric neurology resident Hannah Snyder
Education, Feature
6 days ago